{
    "title": "AstraZeneca says data confirms Enhertu benefit in breast cancer patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11112173/AstraZeneca-Daiichis-breast-cancer-drug-improves-survival-study.html",
    "date": "2022-08-15",
    "keywords": [
        "cancer",
        "breast",
        "drug",
        "trial",
        "disease",
        "grover",
        "pushkala",
        "enhertu",
        "destinybreast02",
        "sankyo",
        "treatment",
        "goal",
        "survival",
        "astrazeneca",
        "approval",
        "latestage",
        "benefit",
        "form",
        "therapy",
        "population",
        "destinybreast01",
        "midstage",
        "basis",
        "europe",
        "study",
        "improvement",
        "measure",
        "person",
        "conference",
        "her2",
        "protein",
        "growth",
        "spread",
        "morning",
        "month",
        "daiichi",
        "her2low",
        "way",
        "enhertus",
        "thirdline",
        "lung",
        "class",
        "antibody",
        "compound",
        "deal",
        "reporting",
        "aripaka",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}